Indian Council of Medical Research to adopt UN agency's standards on clinical trials
Indian Council of Medical Research (ICMR), along with other global health bodies, have decided to adopt UN health agency's recommendations on clinical trials.
United Nations: India's apex medical research body along with other leading groups around the world will adopt UN health agency's recommendations to register and publicly disclose results of all clinical trials they fund or support.
The Indian Council of Medical Research (ICMR), the Norwegian Research Council, the UK Medical Research Council, Medecins Sans Frontieres and Epicentre (its research arm), the Coalition for Epidemic Preparedness Innovations (CEPI), Institut Pasteur, the Bill & Melinda Gates Foundation and the Wellcome Trust have agreed to develop and implement policies within the next 12 months that require all trials they fund, co-fund, sponsor or support to be registered in a publicly-available registry.
They have also agreed that all results would be disclosed within specified time-frames on the registry or by publication in scientific journals.
"We need timely clinical trial results to inform clinical care practices as well as make decisions about allocation of resources for future research," Dr Soumya Swaminathan, Director-General of ICMR, said.
"We welcome the agreement of international standards for reporting time-frames that everyone can work towards," Swaminathan said.
Currently, about 50 per cent of clinical trials go unreported, according to several studies, often because the results are negative. These unreported trial results leave an incomplete and potentially misleading picture of the risks and benefits of vaccines, drugs and medical devices, and can lead to use of suboptimal or even harmful products.
"Research funders are making a strong statement that there will be no more excuses on why some clinical trials remain unreported long after they have been completed," said Dr Marie-Paule Kieny, Assistant Director-General for Health Systems and Innovation at the World Health Organisation.
The signatories to the statement also agreed to monitor compliance with registration requirements and to endorse the development of systems to monitor results reporting.
In 2015, WHO published its position on public disclosure of results from clinical trials, which defines time-frames within which results should be reported, and calls for older unpublished trials to be now reported. That position builds on the 2013 World Medical Association's Declaration of Helsinki.
Saturday's agreement by some of the world's major research funders and international NGOs will mean the ethical principles described in both statements will now be enforced in thousands of trials every year.
Most of these trials and their results will be accessible via WHO's International Clinical Trials Registry Platform, a unique global database of clinical trials that compiles data from 17 registries around the world.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
WHO emergencies director hailed the 'tremendous amount of scientific investigation' done by the Chinese, but said international experts needed to be reassured about the quality of the science
Viral load found to be higher in asymptomatic COVID-19 patients, lower in those who are older: Study
It took quite a while since the COVID-19 pandemic began for medical professionals to understand the transmissibility of the SARS-CoV-2 virus and how patients with or without symptoms help spread the disease further
Biological E starts Phase I/II trial, Bharat Bio to begin Phase III trials for COVID-19 vaccine candidates
Both the vaccines candidates will be administered in two doses via intramuscular injections 28 days apart.